{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:14:08Z","timestamp":1792073648902,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clindermatol.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T14:22:30Z","timestamp":1382538150000},"page":"712-717","source":"Crossref","is-referenced-by-count":24,"title":["Solar keratoses: Photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies"],"prefix":"10.1016","volume":"31","author":[{"given":"Adam R.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.05.007_bb0005","doi-asserted-by":"crossref","unstructured":"Schwartz RA. The actinic keratosis. A perspective and update. Dermatol Surg. 1997;23:1009,19; quiz 1020-1021.","DOI":"10.1111\/j.1524-4725.1997.tb00438.x"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","article-title":"Actinic keratosis","volume":"46","author":"Rossi","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(97)70265-2","article-title":"Actinic keratoses","volume":"36","author":"Callen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0020","first-page":"599","article-title":"Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses","volume":"16","author":"Stockfleth","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clindermatol.2003.12.006","article-title":"The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes","volume":"22","author":"Anwar","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American academy of dermatology association and the society for investigative dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1524-4725.2006.32228.x","article-title":"Frequency and cost of actinic keratosis treatment","volume":"32","author":"Warino","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0040","unstructured":"Holmes C, Foley P, Freeman M, Chong AH. Solar keratosis: Epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol. 2007;48:67,74; quiz 75-76."},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archderm.1997.03890460087010","article-title":"The molecular basis of nonmelanoma skin cancer: new understanding","volume":"133","author":"Grossman","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0050","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the veterans affairs topical tretinoin chemoprevention trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1986.tb06644.x","article-title":"Spontaneous remission of solar keratoses: The case for conservative management","volume":"115","author":"Marks","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0065","first-page":"335","article-title":"Actinic keratosis: How to differentiate the good from the bad ones?","volume":"16","author":"Quaedvlieg","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","article-title":"Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma","volume":"37","author":"Mittelbronn","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archderm.142.8.976","article-title":"Facial resurfacing for nonmelanoma skin cancer prophylaxis","volume":"142","author":"Hantash","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1991.01680060103013","article-title":"Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective","volume":"127","author":"Dodson","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archdermatol.2009.378","article-title":"Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression","volume":"146","author":"Padilla","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/bjc.1996.534","article-title":"Non-melanoma skin cancer and solar keratoses. I. methods and descriptive results of the south wales skin cancer study","volume":"74","author":"Harvey","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1523-1747.2000.00048.x","article-title":"High incidence and regression rates of solar keratoses in a queensland community","volume":"115","author":"Frost","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.1987.tb04126.x","article-title":"Solar keratosis: Fallacies in measuring remission rate and conversion rate to squamous cell carcinoma","volume":"117","author":"Commens","year":"1987","journal-title":"Br J Dermatol"},{"issue":"1 Pt 1","key":"10.1016\/j.clindermatol.2013.05.007_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1067\/mjd.2000.107497","article-title":"The nature of solar keratosis: a critical review in historical perspective","volume":"43","author":"Heaphy","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.clindermatol.2013.05.007_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70119-2","article-title":"Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation","volume":"41","author":"Guenthner","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2013.05.007_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification","volume":"156","author":"Rowert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1 Pt 2","key":"10.1016\/j.clindermatol.2013.05.007_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\u201cactinic keratosis\u201d)","volume":"42","author":"Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2133.2005.07121.x","article-title":"Solar (actinic) keratosis is squamous cell carcinoma","volume":"155","author":"Ackerman","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0130","series-title":"Evidence based dermatology","article-title":"Treatment of actinic keratosis","author":"Carlson","year":"2011"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2013.05.007_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","article-title":"A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up","volume":"157","author":"Krawtchenko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0140","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1524-4725.2000.99197.x","article-title":"Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison","volume":"26","author":"Chiarello","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses","volume":"156","author":"de Berker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.det.2006.09.006","article-title":"Photodynamic therapy for actinic keratoses","volume":"25","author":"Kalisiak","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0155","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1468-3083.2009.03259.x","article-title":"Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00128071-200304030-00001","article-title":"Photodynamic therapy: is it a valuable treatment option for actinic keratoses?","volume":"4","author":"Chamberlain","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2133.2005.06991.x","volume":"154","author":"Langan","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mjd.2002.119649","article-title":"Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study","volume":"47","author":"Szeimies","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0175","first-page":"548","article-title":"Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in the medical literature","volume":"69","author":"Ebell","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0190-9622(82)70143-4","article-title":"Cryosurgery cure rate of actinic keratoses","volume":"7","author":"Lubritz","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","article-title":"A prospective study of the use of cryosurgery for the treatment of actinic keratoses","volume":"43","author":"Thai","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/09546630903341937","article-title":"Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment","volume":"21","author":"Kaur","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-4632.2009.04045.x","article-title":"Effectiveness of 5-fluorouracil treatment for actinic keratosis\u2013a systematic review of randomized controlled trials","volume":"48","author":"Askew","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10227-005-0148-6","article-title":"Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies","volume":"9","author":"Gupta","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0205","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","article-title":"Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis","volume":"24","author":"Loven","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0210","first-page":"156","article-title":"Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp","volume":"5","author":"Smith","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.jid.5700264","article-title":"Imiquimod for actinic keratosis: systematic review and meta-analysis","volume":"126","author":"Hadley","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials","volume":"141","author":"Korman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaad.2006.05.030","article-title":"Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials","volume":"55","author":"Falagas","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0230","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0235","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00128071-200304030-00007","article-title":"Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses","volume":"4","author":"Jarvis","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","article-title":"Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies","volume":"297","author":"Pirard","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0245","first-page":"669","article-title":"Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery","volume":"7","author":"Berlin","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630701818870","article-title":"Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis","volume":"19","author":"Kose","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.05.007_bb0255","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.clindermatol.2013.05.007_bb0260","first-page":"5","article-title":"Matching patients with therapy","volume":"74","author":"Jorizzo","year":"2004","journal-title":"Cutis"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T06:08:26Z","timestamp":1564553306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0738081X13000746"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.05.007","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}